Beacon Pointe Advisors’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Hold |
18,845
| – | – | ﹤0.01% | 1219 |
|
|
2025
Q1 | $38.3K | Buy |
+18,845
| New | +$38.3K | ﹤0.01% | 1180 |
|
|
2024
Q2 | – | Sell |
-18,858
| Closed | -$851K | – | 1255 |
|
|
2024
Q1 | $851K | Hold |
18,858
| – | – | 0.01% | 739 |
|
|
2023
Q4 | $890K | Hold |
18,858
| – | – | 0.01% | 699 |
|
|
2023
Q3 | $763K | Buy |
+18,858
| New | +$763K | 0.01% | 710 |
|
|
2023
Q1 | – | Sell |
-18,884
| Closed | -$6.49M | – | 1151 |
|
|
2022
Q4 | $6.49M | Buy |
+18,884
| New | +$6.49M | 0.13% | 162 |
|